Articles tagged with “computational-biology”

Analyze the integration of agentic AI systems in pharmaceutical R&D, examining Incyte's adoption of the Kosmos AI Scientist for automated drug discovery.

An in-depth analysis of Isomorphic Labs' $2.1B Series B funding. Examine the IsoDDE AI drug design engine, AlphaFold's role, and biotech industry impacts.

Examine the $2.25B Eli Lilly-Profluent deal. Learn how generative AI and protein design are creating novel recombinases for kilobase-scale genome editing.

Examine how Isomorphic Labs uses AlphaFold AI to advance its first computationally designed oncology and immunology therapeutics into clinical trials.

An overview of the $1B NVIDIA-Eli Lilly AI lab, detailing its 5-year compute strategy, DGX SuperPOD infrastructure, and foundation models for drug discovery.

Examine how UVA's YuelDesign uses 3D AI diffusion models in drug discovery. Learn how co-designing ligands with flexible protein pockets improves binding.

Analyze the Chai Discovery and Eli Lilly partnership in AI biologics design. Examine how generative models like Chai-2 impact antibody drug development.

Analyze the Boltz-Pfizer AI drug discovery partnership. This report examines the application of open-source biomolecular foundation models in pharma R&D.

Read an analysis of Amazon Bio Discovery, an AWS agentic AI platform integrating biological foundation models and wet-lab workflows for drug development.

An in-depth analysis of the Amazon Bio Discovery platform. Learn how AWS uses agentic AI, biological foundation models, and integrated wet labs for drug R&D.

Analyze Anthropic's $400M acquisition of Coefficient Bio. This report details the integration of large language models and AI in pharmaceutical drug discovery.

Learn how OpenAI Codex assists biotech research by automating bioinformatics tasks. Read our analysis of its technical capabilities, use cases, and limitations.

Explore practical applications of Claude Code in life sciences. This guide covers its use in genomics, bioinformatics, and R&D automation via tool connectors. L

An educational guide to HPC in life sciences. We review top lab IT specialists and solutions for genomics, drug discovery, and bioinformatics data analysis.

Updated 2026: Learn what NVIDIA BioNeMo is and how it accelerates drug discovery. This guide explains its components, latest models (RNAPro, ReaSyn v2), the $1B Lilly partnership, and deployment for generative AI in biopharma.

Profiles of leading US researchers and industry pioneers applying generative AI to pharmaceutical R&D, drug discovery, protein design, and clinical trials – updated with 2025-2026 milestones including Phase II/III results, major funding rounds, and regulatory breakthroughs.

A comprehensive analysis of how pharmaceutical and biotech companies are leveraging NVIDIA's latest H100 and Blackwell GPUs to accelerate drug discovery, protein structure prediction, and AI-driven research, with detailed case studies from leading companies.